Apyx Medical Corp
corporate_fare Company Profile
Apyx Medical Corp (NASDAQ:APYX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for APYX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for APYX spans 10-Q, DEF 14A, 8-K, 10-K.
Recent high-impact activity:
- Apyx Medical Posts $14M in Third-Quarter Sales
- Apyx Medical Q2 Revenue Climbs 22% to $13.9M, Full-Year Guidance Reaffirmed
- Apyx Medical Proposes New Share Incentive Plan with 9.5% Potential Dilution
- Apyx Medical Appoints Stavros Vizirgianakis as Executive Chairman, Grants $1.9M in RSUs
- Apyx Medical Study Shows Up to 81.8% Cellulite Improvement with Combined Avéli and Renuvion
Financial Snapshot
Short Interest & Short Volume
2.08 days to coverFINRA reported short interest of 245,424 shares in APYX as of the October 30, 2026 settlement, a 14.8% increase from the prior period — about 2.1 days to cover at its recent average daily volume. On November 20, 2026, 11.7% of APYX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.